- $9.28bn
- $10.91bn
- $10.55bn
- 56
- 55
- 92
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,433 | 9,286 | 12,152 | 12,451 | 10,551 |
Cost of Revenue | |||||
Gross Profit | 1,896 | 1,317 | 2,999 | 2,239 | 738 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,588 | 8,778 | 11,203 | 11,761 | 10,894 |
Operating Profit | -155 | 508 | 949 | 690 | -343 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -438 | 173 | 1,199 | 702 | -584 |
Provision for Income Taxes | |||||
Net Income After Taxes | -853 | -14 | 570 | 38 | -773 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,125 | -170 | 429 | -123 | -651 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,125 | -170 | 429 | -123 | -651 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.47 | -1.16 | 4.19 | 1.86 | -2.93 |
Dividends per Share |